73 related articles for article (PubMed ID: 18403458)
1. Effect of statins on serum apolipoprotein j and paraoxonase-1 levels in patients with ischemic heart disease undergoing coronary angiography.
Poulakou MV; Paraskevas KI; Vlachos IS; Karabina SA; Wilson MR; Iliopoulos DC; Tsitsilonis SI; Mikhailidis DP; Perrea DN
Angiology; 2008; 59(2):137-44. PubMed ID: 18403458
[TBL] [Abstract][Full Text] [Related]
2. Association of lipid profile with serum PON1 concentration in patients with chronic kidney disease.
Samouilidou E; Kostopoulos V; Liaouri A; Kioussi E; Vassiliou K; Bountou E; Grapsa E
Ren Fail; 2016 Nov; 38(10):1601-1606. PubMed ID: 26888625
[TBL] [Abstract][Full Text] [Related]
3. Low paraoxonase 1 arylesterase activity and high von Willebrand factor levels are associated with severe coronary atherosclerosis in patients with non-diabetic stable coronary artery disease.
Ding J; Chen Q; Zhuang X; Feng Z; Xu L; Chen F
Med Sci Monit; 2014 Nov; 20():2421-9. PubMed ID: 25420483
[TBL] [Abstract][Full Text] [Related]
4. The relationships between PON1 activity as well as oxLDL levels and coronary artery lesions in CHD patients with diabetes mellitus or impaired fasting glucose.
Lu C; Gao Y; Zhou H; Tian H
Coron Artery Dis; 2008 Dec; 19(8):565-73. PubMed ID: 19005291
[TBL] [Abstract][Full Text] [Related]
5. Low serum paraoxonase1 activity levels predict coronary artery disease severity.
Sun T; Hu J; Yin Z; Xu Z; Zhang L; Fan L; Zhuo Y; Wang C
Oncotarget; 2017 Mar; 8(12):19443-19454. PubMed ID: 28038449
[TBL] [Abstract][Full Text] [Related]
6. [Correlation of high-sensitivity CRP concentration with the extent of coronary atherosclerosis in men with symptoms of ischemic heart disease].
Piechota W; Piechota W
Pol Merkur Lekarski; 2005 May; 18(107):511-5. PubMed ID: 16161944
[TBL] [Abstract][Full Text] [Related]
7. Serum apolipoprotein j in health, coronary heart disease and type 2 diabetes mellitus.
Kujiraoka T; Hattori H; Miwa Y; Ishihara M; Ueno T; Ishii J; Tsuji M; Iwasaki T; Sasaguri Y; Fujioka T; Saito S; Tsushima M; Maruyama T; Miller IP; Miller NE; Egashira T
J Atheroscler Thromb; 2006 Dec; 13(6):314-22. PubMed ID: 17192696
[TBL] [Abstract][Full Text] [Related]
8. Main determinants of PON1 activity in hemodialysis patients.
Ribeiro S; do Sameiro Faria M; Mascarenhas-Melo F; Freitas I; Mendonça MI; Nascimento H; Rocha-Pereira P; Miranda V; Mendonça D; Quintanilha A; Belo L; Costa E; Reis F; Santos-Silva A
Am J Nephrol; 2012; 36(4):317-23. PubMed ID: 23007074
[TBL] [Abstract][Full Text] [Related]
9. Association of paraoxonase-1 activity and concentration with angiographic severity and extent of coronary artery disease.
Granér M; James RW; Kahri J; Nieminen MS; Syvänne M; Taskinen MR
J Am Coll Cardiol; 2006 Jun; 47(12):2429-35. PubMed ID: 16781370
[TBL] [Abstract][Full Text] [Related]
10. Effects of caloric restriction and gender on rat serum paraoxonase 1 activity.
Thomàs-Moyà E; Gianotti M; Lladó I; Proenza AM
J Nutr Biochem; 2006 Mar; 17(3):197-203. PubMed ID: 16214326
[TBL] [Abstract][Full Text] [Related]
11. Apolipoprotein modifying effects of statins and fibrate in various age groups of coronary artery disease patients.
Sharma R; Mahajan M; Singh B; Bal BS; Kant R
J Indian Med Assoc; 2006 Sep; 104(9):492-4, 496, 498. PubMed ID: 17388006
[TBL] [Abstract][Full Text] [Related]
12. Gender related differences in paraoxonase 1 response to high-fat diet-induced oxidative stress.
Thomàs-Moyà E; Gómez-Pérez Y; Fiol M; Gianotti M; Lladó I; Proenza AM
Obesity (Silver Spring); 2008 Oct; 16(10):2232-8. PubMed ID: 18719679
[TBL] [Abstract][Full Text] [Related]
13. Effect of paraoxonase 1 polymorphisms on the response of lipids and lipoprotein-associated enzymes to treatment with fluvastatin.
Christidis DS; Liberopoulos EN; Kakafika AI; Miltiadous GA; Liamis GL; Kakaidi B; Tselepis AD; Cariolou MA; Elisaf MS
Arch Med Res; 2007 May; 38(4):403-10. PubMed ID: 17416287
[TBL] [Abstract][Full Text] [Related]
14. Results of a retrospective database analysis of adherence to statin therapy and risk of nonfatal ischemic heart disease in daily clinical practice in Italy.
Corrao G; Conti V; Merlino L; Catapano AL; Mancia G
Clin Ther; 2010 Feb; 32(2):300-10. PubMed ID: 20206788
[TBL] [Abstract][Full Text] [Related]
15. Effect of fish oil supplements on serum paraoxonase activity in female patients with rheumatoid arthritis: a double-blind randomized controlled trial.
Ghorbanihaghjo A; Kolahi S; Seifirad S; Rashtchizadeh N; Argani H; Hajialilo M; Khabazi A; Alizadeh S; Bahreini E
Arch Iran Med; 2012 Sep; 15(9):549-52. PubMed ID: 22924372
[TBL] [Abstract][Full Text] [Related]
16. Effect of statin therapy on paraoxonase-1 status: A systematic review and meta-analysis of 25 clinical trials.
Ferretti G; Bacchetti T; Sahebkar A
Prog Lipid Res; 2015 Oct; 60():50-73. PubMed ID: 26416579
[TBL] [Abstract][Full Text] [Related]
17. Associations of plasma C-reactive protein levels with the presence and extent of coronary stenosis in patients with stable coronary artery disease.
Taniguchi H; Momiyama Y; Ohmori R; Yonemura A; Yamashita T; Tamai S; Nakamura H; Ohsuzu F
Atherosclerosis; 2005 Jan; 178(1):173-7. PubMed ID: 15585215
[TBL] [Abstract][Full Text] [Related]
18. Apolipoprotein J and leptin levels in patients with coronary heart disease.
Poulakou MV; Paraskevas KI; Wilson MR; Iliopoulos DC; Tsigris C; Mikhailidis DP; Perrea D
In Vivo; 2008; 22(4):537-42. PubMed ID: 18712185
[TBL] [Abstract][Full Text] [Related]
19. Modulating effect of atorvastatin on paraoxonase 1 activity in type 2 diabetic Egyptian patients with or without nephropathy.
Abdin AA; Hassanien MA; Ibrahim EA; El-Noeman Sel-D
J Diabetes Complications; 2010; 24(5):325-33. PubMed ID: 19553142
[TBL] [Abstract][Full Text] [Related]
20. Hyperhomocysteinemia, paraoxonase activity and risk of coronary artery disease.
Kerkeni M; Addad F; Chauffert M; Chuniaud L; Miled A; Trivin F; Maaroufi K
Clin Biochem; 2006 Aug; 39(8):821-5. PubMed ID: 16875684
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
